nps-568 has been researched along with Body Weight in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furuya, Y; Ishii, H; Kobayashi, N; Miyata, S; Nagano, N; Sakiyama, J; Wada, M | 1 |
Chin, J; Fox, J; Furuya, Y; Nagano, N; Nemeth, EF; Wada, M | 1 |
Fox, J; Miller, MA | 1 |
3 other study(ies) available for nps-568 and Body Weight
Article | Year |
---|---|
The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor.
Topics: Aniline Compounds; Animals; Apoptosis; Blood Urea Nitrogen; Body Weight; Calcitriol; Calcium; Cell Division; Creatinine; Disease Models, Animal; Growth Inhibitors; Male; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley; Renal Insufficiency | 1997 |
Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism.
Topics: Aniline Compounds; Animals; Blood Urea Nitrogen; Body Weight; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Male; Parathyroid Diseases; Parathyroid Hormone; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley | 2000 |
Daily transient decreases in plasma parathyroid hormone levels induced by the calcimimetic NPS R-568 slows the rate of bone loss but does not increase bone mass in ovariectomized rats.
Topics: Aniline Compounds; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Calcium; Osteocalcin; Ovariectomy; Parathyroid Hormone; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley | 2000 |